US equities |
SPCX $159.38 ▲+7.84% MU $915.77 ▲+2.20% NVDA $222.06 ▲+2.58% TSLA $386.62 ▲+3.45% META $699.41 ▲+0.74% SNDK $1,380.51 ▲+1.11% AMD $553.72 ▲+3.55% AAPL $344.10 ▲+1.35%
FinancialContent

Latest News about BECOME/TSC

Recent news which mentions BECOME/TSC

CBD Drug For Tuberous Sclerosis: Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And Cognitive Improvements
Tickers JAZZ NEWS
Tags tuberous sclerosis complex cannabis CBD medicine Sarah Akerman
From Benzinga